Lv11
52 积分 2024-08-19 加入
Development of Selective Covalent Janus Kinase 3 Inhibitors
1小时前
已完结
Discovery of novel dual Bruton’s tyrosine kinase (BTK) and Janus kinase 3 (JAK3) inhibitors as a promising strategy for rheumatoid arthritis
20天前
已完结
Discovery and structural characterization of peficitinib (ASP015K) as a novel and potent JAK inhibitor
1个月前
已完结
Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia
1个月前
已完结
A Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: Safety and Efficacy Results from a Phase 1 Study
3个月前
已关闭
Pre-Clinical Evaluation of a New-Generation Orally Bioavailable Dual Bcl-2/Bcl-Xl Inhibitor LP-118 in Mantle Cell Lymphoma
3个月前
已完结
Characterization of LP-118, a Novel Small Molecule Inhibitor of Bcl-2 and Bcl-Xl in Chronic Lymphocytic Leukemia Resistant to Venetoclax
3个月前
已关闭
皖公网安备34019202002308
